Connect with us

Market Foresight

Global immunoassay market to rise high with rapid development of biopharmaceutical sector

The global market for immunoassay is fragmented in nature with a high number of players engaged in it across the globe. The rapid development of the healthcare sector and the increasing investments by the leading players, especially for research and development activities, is estimated to enhance the market development and strengthen the competitive scenario of the market over the next few years. Moreover, the rising number of partnerships and mergers and the technological developments in this area are projected to enhance the growth of the global immunoassay market in the coming few years. In 2017, the global market for immunoassay stood at USD 16.54 billion and is estimated to reach a value of USD 28.61 billion by the end of 2026, exhibiting a healthy 6.20 percent CAGR, predicts Transparency Market Research.

A significant rise in the incidence of infectious and chronic diseases and the tremendously rising geriatric population are the key factors encouraging the growth of the global immunoassay market in the next few years. The rise in the use of immunoassay in the field of oncology and the increasing focus of the key players on technological developments is further predicted to support the development of the market in the near future. In addition to this, the advent of effective and novel automated systems and the rapid development of the biotechnology and biopharmaceutical industries are estimated to accelerate the overall growth of the market in the coming years. Furthermore, the rise in the adoption of immunoassay-based testing for point-of-care and the important role that is played by immunoassay in the alcohol and drugs testing are some of the other aspects that are predicted to ensure the growth of the market in the near future. In addition to this, the integration of the microfluidics technology in immunoassay is anticipated to enhance the market growth over the next few years.

The global immunoassay market is estimated to face a few challenges in the market, due to which the market is likely to experience a slight downfall in the next few years. The increasing complexities in performing the diagnostic tests and the unfavorable reimbursement scenario are the main factors that are predicted to hamper the market growth in the near future. Moreover, the strict rules and regulations regarding the approval of immunoassay consumables and instruments are expected to curb the market growth in the near future. Nonetheless, the increasing potential opportunities in the developing nations and the advent of condition-specific tests and biomarkers are expected to accelerate the market development in the coming few years. Also, the rising consumer awareness for companion diagnostics is likely to supplement the market growth in the next few years.

Copyright © 2024 Medical Buyer

error: Content is protected !!